Created in 2011 (United States), POML own
126 sister brands
and 17478 competing brands.
POML is a brand of Celgene, listed on the stock exchange of New York.
The sector of POML is Drug Manufacturers.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.